Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment
Open Access
- 6 July 2022
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 20 (1) , 1-20
Abstract
Background: Tumour-derived exosomes have recently been shown to participate in the formation and progression of different cancer processes, including tumour microenvironment remodelling, angiogenesis, invasion, metastasis, and drug resistance. However, the function and mechanism of exosome-encapsulated nucleic acids and proteins in bladder cancer remain unclear. This study aimed to investigate the effects of tumour-derived exosomes on the tumorigenesis and development of bladder cancer. Methods: In this study, gene expression profiles and clinical information were collected from The Cancer Genome Atlas (TCGA) database and two independent Gene Expression Omnibus (GEO) datasets. The nucleic acids and proteins encapsulated in bladder cancer-derived exosomes were obtained from the ExoCarta database. Based on these databases, the expression patterns of exosomal mRNAs and proteins and the matched clinicopathological characteristics were analysed. Furthermore, we carried out a series of experiments to verify the relevant findings. Results: A total of 7280 differentially expressed mRNAs were found in TCGA data, of which 52 mRNAs were shown to be encapsulated in bladder cancer-derived exosomes. Survival analysis based on the UALCAN database showed that among the top 10 upregulated and the top 10 downregulated exosomal genes, only the expression of KRT6B had a statistically significant effect on the survival of bladder cancer patients. Additionally, clinical correlation analysis showed that the elevated level of KRT6B was highly associated with bladder cancer stage, grade, and metastasis status. GSEA revealed that KRT6B was involved not only in epithelial–mesenchymal transition-related pathways but also in the immune response in bladder cancer. Ultimately, our experimental results were also consistent with the bioinformatic analysis. Conclusion: KRT6B, which can be detected in bladder cancer-derived exosomes, plays an important role in the epithelial–mesenchymal transition and immune responses in bladder cancer. Further research will enable its potentially prognostic marker and therapeutic target for bladder cancer.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (82073306)
This publication has 33 references indexed in Scilit:
- Extracellular Vesicles and Their Role in Urologic MalignanciesEuropean Urology, 2016
- Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60Clinical Cancer Research, 2015
- Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomesOncogenesis, 2015
- Tissue-based map of the human proteomeScience, 2015
- Tumor-derived exosomes in oncogenic reprogramming and cancer progressionCellular and Molecular Life Sciences, 2014
- Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancerJournal of Experimental & Clinical Cancer Research, 2013
- Extracellular vesicles: Exosomes, microvesicles, and friendsJournal of Cell Biology, 2013
- Biomarkers for epithelial-mesenchymal transitionsJournal of Clinical Investigation, 2009
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003